RevealDx

by RevealDx  · Based in United States → — Dramatically improve lung cancer outcomes using non-invasive diagnosis.
Oncology Pulmonology Radiology

Reimbursable by medicare for us clinical use at a rate of $650.

Overview

RevealAI-Lung by RevealDx is an AI-powered Computer-Aided Diagnosis (CADx) software designed to assist radiologists in evaluating incidental lung nodules on chest CT scans.

  • What it does: The software generates a Malignancy Similarity Index (mSI), a quantitative score that characterizes a detected lung nodule and provides a risk assessment. This score is intended to support clinicians in making informed follow-up recommendations.
  • Who it is for: RevealAI-Lung is primarily for radiologists and other healthcare professionals involved in lung nodule assessment and lung cancer screening programs.
  • How it fits a clinical or practice workflow: A notable feature is its direct integration into Picture Archiving and Communication Systems (PACS), aiming to minimize disruption to existing routines. The mSI can be computed with a single click and results are displayed within seconds, allowing for integration into the radiology report.
  • Notable capabilities: The software utilizes real-world data from the National Lung Screening Trial (NLST) as a reference population for its scoring. It is designed to be generalizable across different exam types and patient populations. RevealDx has also partnered with other companies for distribution and integration, including Sirona Medical and Riverain Technologies.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered lung nodule characterization
  • CT scan analysis
  • Differentiation of benign vs. malignant nodules
  • Quantitative and qualitative data insights
  • Integration into clinical workflows
  • Supports diagnostic confidence
  • Non-invasive assessment

Use Cases

  • Early lung cancer detection
  • Lung nodule management
  • Reducing unnecessary invasive procedures
  • Enhancing diagnostic accuracy in radiology
  • Supporting treatment planning in oncology

Details

Category Clinical Decision Support & Reference, Lab & Diagnostics, Radiology & Imaging AI
Pricing Reimbursable by medicare for us clinical use at a rate of $650.
DeploymentIntegrates directly into PACS.
Mobile AppNone
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Unknown
Integrations
EHR Not specified
Specialties Oncology, Pulmonology, Radiology, Thoracic Surgery

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate RevealDx

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for RevealDx.

View all on YouTube

Frequently Asked Questions

RevealDx is a Seattle-based software company that provides AI-enabled lung cancer decision support software, specifically RevealAI-Lung. It characterizes incidental lung nodules by generating a Malignancy Similarity Index (mSI) score, which helps radiologists assess the likelihood of cancer and make more informed follow-up recommendations.
RevealAI-Lung has received FDA clearance in the US (January 2026) and MDR Certification in Europe (November 2025). It also has market authorization for clinical use in Canada, Australia, New Zealand, and is registered for use in the UK.
RevealAI-Lung is designed for single-click operation and integrates directly into Picture Archiving and Communication Systems (PACS), minimizing disruption to radiologists' routines. Key features include generating the mSI score, providing actionable radiomic insights, and supporting consistent follow-up recommendations.
Benefits include accelerating diagnosis, reducing false positives, potentially identifying malignant nodules earlier, and decreasing unnecessary procedures, which can lead to significant cost savings. While the software is validated on over 1,500 patients, it is intended to complement other clinical information rather than provide an independent diagnosis.
In the US, RevealAI-Lung is reimbursable by Medicare under the Outpatient Prospective Payment System (OPPS) using codes 0721T and 0722T, at a rate of approximately $650. Specific pricing plans for direct purchase are not publicly detailed, but the company emphasizes significant cost savings through reduced unnecessary procedures.
Yes, there are several alternatives in the market. Some companies offering AI-powered lung nodule solutions include contextflow (ADVANCE Chest CT), Riverain (ClearRead CT), Qure AI (qCT-Lung & qCT LN Quant), Coreline (AVIEW LCS), and DeepHealth (Chest Suite). Other general EHR and practice management alternatives mentioned include Epic, Carepatron, and ModMed.
RevealDx states that its software has been extensively validated in clinical trials and years of research, including validation on over 1,500 patients from various cohorts. Studies have demonstrated its ability to improve early cancer detection rates and reduce false positives.

Related Tools

Stanford University
Stanford University
Clinical Decision Support & Reference
Stanford Online's "AI in Healthcare" program provides a comprehensive overview of artificial intelligence's applications and implications within the medical field.
RADIN Health
RADIN Health
Clinical Decision Support & Reference
RADINA is an AI-powered platform by RADIN Health designed to optimize radiology workflows, enhance diagnostic accuracy, and streamline reporting.
Med-PaLM 2
Google
Clinical Decision Support & Reference
Med-PaLM 2 is a large language model from Google, fine-tuned for healthcare to provide high-quality answers to medical questions and support clinical decision-making.
Pacmed Critical Discharge
Pacmed
Clinical Decision Support & Reference
Pacmed Critical Discharge is an AI tool that predicts the probability of death or readmission within seven days of ICU discharge, providing explainable insights for physicians.
AiZtech Labs
AiZtech Labs
Clinical Decision Support & Reference
AiZtech Labs provides enterprise-grade AI solutions for healthcare, focusing on operational efficiency, diagnostic accuracy, and patient care workflows for providers and health systems.
Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-08-24 | First Added: 2026-08-23
AI Tool Finder
AI-powered search. Results may not be comprehensive.